Free Trial

180 Life Sciences (ATNF) Insider Trading & Ownership

180 Life Sciences logo
$1.86 -0.08 (-4.12%)
(As of 12/20/2024 05:45 PM ET)

180 Life Sciences (NASDAQ:ATNF) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.17%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$65,380.52
Number Of
Insiders Selling
(Last 3 Years)
0
Get ATNF Insider Trade Alerts

Want to know when executives and insiders are buying or selling 180 Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ATNF Insider Buying and Selling by Quarter

180 Life Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2023Jr. Donald A McgovernDirectorBuy526$21.85$11,493.10  
5/18/2023James N WoodyCEOBuy2,105$19.57$41,194.85  
5/18/2023Ozan PamirCFOBuy271$19.19$5,200.49  
5/18/2023Pamela G MarroneDirectorBuy372$20.14$7,492.08  
(Data available from 1/1/2013 forward)

ATNF Insider Trading Activity - Frequently Asked Questions

The list of insiders at 180 Life Sciences includes James N Woody, Jr. Donald A Mcgovern, Ozan Pamir, and Pamela G Marrone. Learn more on insiders at ATNF.

0.17% of 180 Life Sciences stock is owned by insiders. Learn more on ATNF's insider holdings.

The following insiders have purchased ATNF shares in the last 24 months: James N Woody ($41,194.85), Jr. Donald A Mcgovern ($11,493.10), Ozan Pamir ($5,200.49), and Pamela G Marrone ($7,492.08).

Insiders have purchased a total of 3,274 ATNF shares in the last 24 months for a total of $65,380.52 bought.

180 Life Sciences Key Executives

  • Dr. Lawrence Steinman BA (Age 76)
    M.D., Ph.D., Co-Founder & Executive Chairman
    Compensation: $168.75k
  • Dr. James N. Woody M.D. (Age 82)
    Ph.D., CEO & Director
    Compensation: $617.77k
  • Mr. Ozan Pamir C.F.A. (Age 32)
    CFO & Secretary
    Compensation: $410.24k
  • Dr. Jonathan B. Rothbard Ph.D. (Age 71)
    Chief Scientific Officer
    Compensation: $260.34k
  • Prof. Jagdeep Nanchahal
    Co-Founder & Chairman of Clinical Advisory Board
  • Mr. Jason Assad
    Director of IR


This page (NASDAQ:ATNF) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners